Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by enriquesuave

V.TLT

RE:RE:RE:RE:RE:New Data Format

I would say more around 45-55% durable CR as some of the IR patients convert...

April 27, 2023

V.TLT

RE:RE:RE:New Data Format

Th KM curve includes the 12 undertreated patients as it's the same data...

April 27, 2023

V.TLT

RE:stock price

Looks like we need more investor awareness which will hopefully come after...

April 27, 2023

V.TLT

RE:Data

https://biotuesdays.com/2023/04/27/research-capital-remains-bullish-of...

April 27, 2023

V.TLT

Data

90 days data ( n=52) includes all patients even initial 12 undertreated...

April 27, 2023

V.TLT

RE:Study II data table in April 26 news release.

No Swimmers plot shows initial 12 are still there only at 90 days,and not at...

April 27, 2023

V.TLT

RE:The FDA cannot turn down such treatment

Exactly!  What the data clearly shows is a high CR efficacy and a very...

April 27, 2023

V.TLT

RE:RE:Wow. Simply tremendous.

This patient had passed away from Heart failure, unfortunately.  Looks...

April 27, 2023

V.TLT

RE:RE:So they STILL have not applied for BTD???

Rumpl3StiltSkin wrote: They will probably apply for BTD once they pass the...

April 26, 2023

V.TLT

RE:RE:Only 12 Evaluable Patients at 450 days 67% CR !!!!!!

enriquesuave wrote: Maybe at 450 days they are only counting PH2 patients...

April 26, 2023

V.TLT

RE:RE:RE:RE:Only 12 Evaluable Patients at 450 days 67% CR !!!!!!

Eoganacht wrote: I'm not sure yet, but I think they may have changed the...

April 26, 2023

V.TLT

RE:Only 12 Evaluable Patients at 450 days 67% CR !!!!!!

Maybe at 450 days they are only counting PH2 patients which got 2 optimized...

April 26, 2023

V.TLT

RE:AUA 2023 Embargo Policy

That means that they will release MD&A on May 1st with new data, and not...

April 26, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:stock behaviour

Th company only reports what the principal investigator releases.  They...

April 26, 2023

V.TLT

RE:RE:RE:RE:RE:stock behaviour

They can't withhold news. They are probably waiting for data fro...

April 26, 2023

V.TLT

RE:Wants out .. or needs out?

Same thing happened last time just before it ran up into the 30's

April 17, 2023

V.TLT

RE:RE:RE:Let the 450 day CR% numbers talk.

We also have IR patients who can be reclassified as either CR or NR and if CR...

April 16, 2023

V.TLT

RE:RE:RE:RE:RE:RE:New FDA Proposed Guidance on AA

Th FDA didn't ask Adstiladrin for a RCT.  Adstiladrin had received a...

March 29, 2023

V.TLT

RE:RE:RE:RE:New FDA Proposed Guidance on AA

Adstiladrin just got approved in December with a 24% CR rate at 450 days...

March 29, 2023

V.TLT

RE:RE:RE:It takes money to advance oncology R&D

So far no calls. I can confirm I invested in last PP after a phone call...

March 7, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

NurExone Biologic Inc.

NurExone Biologic Inc. V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »